Ignite Creation Date:
2024-07-17 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06465914
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-06-14
Brief Title:
A Phase III Study to Evaluate the Efficacy Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
Sponsor:
Shanghai Bovax Biotechnology Co Ltd
Organization:
Shanghai Bovax Biotechnology Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Genital Wart |
| Penile Cancer |
| Anal Cancer |
| PIN-1 |
| PIN2 |
| PIN3 |
| AIN1 |
| AIN2 |
| AIN3 |
| HPV-Related Carcinoma |
Keywords: